Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily versus as-needed tadalafil in men with erectile dysfunction
IRCT20260121068634N1Phase 4Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of tadalafil in erectile dysfunction (ED) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: C-reactive protein, Erythrocyte sedimentation rate and 1 more. Started Mar 2026; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on IRCT20260121068634N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260121068634N1.